Proposed Rule for Combo Products Offers Streamlined GMP Option

The GMP Letter
Makers of components in co-packaged or single-entity combination products would have two options for showing compliance with quality system (QS) requirements for devices and cGMPs for drugs or biologics under a new proposed rule.

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $20.00